Newbridge Financial Services Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710 | Buy |
349
+16
| +5% | +$33 | ﹤0.01% | 1225 |
|
|
2025
Q1 | $543 | Hold |
333
| – | – | ﹤0.01% | 971 |
|
|
2024
Q4 | $609 | Hold |
333
| – | – | ﹤0.01% | 1052 |
|
|
2024
Q3 | $1.93K | Hold |
333
| – | – | ﹤0.01% | 566 |
|
|
2024
Q2 | $2.69K | Hold |
333
| – | – | ﹤0.01% | 925 |
|
|
2024
Q1 | $4.62K | Hold |
333
| – | – | ﹤0.01% | 901 |
|
|
2023
Q4 | $2.04K | Sell |
333
-50
| -13% | -$306 | ﹤0.01% | 965 |
|
|
2023
Q3 | $1.79K | Sell |
383
-117
| -23% | -$547 | ﹤0.01% | 1087 |
|
|
2023
Q2 | $2.68K | Hold |
500
| – | – | ﹤0.01% | 1099 |
|
|
2023
Q1 | $4.92K | Hold |
500
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q4 | $9.36K | Hold |
500
| – | – | 0.01% | 926 |
|
|
2022
Q3 | $10K | Hold |
500
| – | – | 0.01% | 882 |
|
|
2022
Q2 | $10K | Hold |
500
| – | – | 0.01% | 866 |
|
|
2022
Q1 | $22K | Hold |
500
| – | – | 0.01% | 700 |
|
|
2021
Q4 | $30K | Hold |
500
| – | – | 0.01% | 609 |
|
|
2021
Q3 | $43K | Hold |
500
| – | – | 0.03% | 454 |
|
|
2021
Q2 | $56K | Hold |
500
| – | – | 0.03% | 402 |
|
|
2021
Q1 | $56K | Buy |
+500
| New | +$56K | 0.04% | 367 |
|